J R ESHLEMAN - JoVE Visualize

Showing results (21-30 of 29) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 29 results.

Hepatology (Baltimore, Md.)|June 8, 2001

An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 regionM Sun, J R Eshleman, L D Ferrell, et al.

Journal of the National Cancer Institute|March 16, 2000

Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cellsW D Chen, J R Eshleman, M R Aminoshariae, et al.

Oncogene|January 5, 1995

Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancerJ R Eshleman, E Z Lang, G K Bowerfind, et al.

Oncogene|August 26, 1998

Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53J R Eshleman, G Casey, M E Kochera, et al.

Oncogene|April 4, 1996

Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instabilityJ R Eshleman, S D Markowitz, P S Donover, et al.

Cancer Research|November 21, 1998

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancerC R Boland, S N Thibodeau, S R Hamilton, et al.

Oncogene|April 7, 1998

Increased transversions in a novel mutator colon cancer cell lineJ R Eshleman, P S Donover, S J Littman, et al.

The American Journal of Pathology|October 20, 1998

Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequencesT Fujiwara, J M Stolker, T Watanabe, et al.

The Prostate|May 6, 2025

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala VariantA Mandl, M L Zahurak, N A Metri, et al.

Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 29 results.

Hepatology (Baltimore, Md.)|June 8, 2001

An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 regionM Sun, J R Eshleman, L D Ferrell, et al.

Journal of the National Cancer Institute|March 16, 2000

Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cellsW D Chen, J R Eshleman, M R Aminoshariae, et al.

Oncogene|January 5, 1995

Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancerJ R Eshleman, E Z Lang, G K Bowerfind, et al.

Oncogene|August 26, 1998

Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53J R Eshleman, G Casey, M E Kochera, et al.

Oncogene|April 4, 1996

Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instabilityJ R Eshleman, S D Markowitz, P S Donover, et al.

Cancer Research|November 21, 1998

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancerC R Boland, S N Thibodeau, S R Hamilton, et al.

Oncogene|April 7, 1998

Increased transversions in a novel mutator colon cancer cell lineJ R Eshleman, P S Donover, S J Littman, et al.

The American Journal of Pathology|October 20, 1998

Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequencesT Fujiwara, J M Stolker, T Watanabe, et al.

The Prostate|May 6, 2025

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala VariantA Mandl, M L Zahurak, N A Metri, et al.

Pageof 3